While federal law has long carved out exceptions for pharmacists to mix custom medications for individual patients, the sheer scale of current operations has blurred the line between traditional pharmacy practice and unapproved manufacturing. For intellectual property (IP) attorneys, regulatory affairs directors, and biopharma executives, the urgent question is no longer theoretical: At what point does the volume, scale, and marketing of a compounded drug cease to be a regulatory exemption and become actionable patent infringement
Drugs like retatrutide, CagriSema, survodutide, and orforglipron promise to address the limitations of current therapies and may unlock new levels of weight loss, health protection, and accessibility
Continue exercising at your established intensity
The naturual coenyze has been linked to mitochondrial function, which can help improve energy, mental clarity and support healthier aging at the cellular level